Peripheral Artery Disease (PAD) Market is segmented By Treatment Type (Surgical Treatment (Bypass Surgery, Bypass Surgery ), Non-Surgical Treatment (M....
Market Size in USD
CAGR6.4%
Study Period | 2024 - 2031 |
Base Year of Estimation | 2023 |
CAGR | 6.4% |
Market Concentration | High |
Major Players | Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Cook Medical, Becton, Dickinson and Company |
The Peripheral Artery Disease (PAD) Market is estimated to be valued at USD 4.04 Billion in 2024 and is expected to reach USD 6.24 Billion by 2031, growing at a compound annual growth rate (CAGR) of 6.4% from 2024 to 2031. The PAD market is expected to witness a steady growth during the forecast period owing to the increasing aging population which is the major risk factor for PAD. Additionally, rising lifestyle diseases such as diabetes and government initiatives to increase awareness about early diagnosis and treatment of PAD will further aid the market growth.